This is what I particularly like! "We are encouraged by the industry response following the positive interim data we reported earlier this year, and look forward to reporting additional data later this year." This is an open label trial and both the company and interested international pharmas know what is happening before we do. The interim data was VERY positive...I look forward to an update and a potential partnership!
News 
Market Data 
Discover 
